Use of letrozole after aromatase inhibitor-based therapy in postmenopausal breast cancer (NRG Oncology/NSABP B-42): a randomised, double-blind, placebo-controlled, phase 3 trial

Eleftherios P. Mamounas, Hanna Bandos, Barry C. Lembersky, Jong Hyeon Jeong, Charles E. Geyer, Priya Rastogi, Louis Fehrenbacher, Mark L. Graham, Stephen K. Chia, Adam M. Brufsky, Janice M. Walshe, Gamini S. Soori, Shaker R. Dakhil, Thomas E. Seay, James L. Wade, Edward C. McCarron, Soonmyung Paik, Sandra M. Swain, D. Lawrence Wickerham, Norman Wolmark